Daniel M. Gordon

4.3k total citations · 1 hit paper
51 papers, 3.4k citations indexed

About

Daniel M. Gordon is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology. According to data from OpenAlex, Daniel M. Gordon has authored 51 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Public Health, Environmental and Occupational Health, 16 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Daniel M. Gordon's work include Malaria Research and Control (38 papers), Mosquito-borne diseases and control (22 papers) and vaccines and immunoinformatics approaches (12 papers). Daniel M. Gordon is often cited by papers focused on Malaria Research and Control (38 papers), Mosquito-borne diseases and control (22 papers) and vaccines and immunoinformatics approaches (12 papers). Daniel M. Gordon collaborates with scholars based in United States, Thailand and Kenya. Daniel M. Gordon's co-authors include Imogene Schneider, Stephen L. Hoffman, Michael R. Hollingdale, D. Gray Heppner, W. Ripley Ballou, Wayne T. Hockmeyer, Robert A. Wirtz, James E. Egan, Jerald Sadoff and W. Ripley Ballou and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Daniel M. Gordon

49 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoites

2002 526 citations Stephen L. Hoffman, Thomas Luke et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel M. Gordon United States	28	2.4k	1.4k	1.1k	519	483	51	3.4k
W. Ripley Ballou United States	31	2.9k 1.2×	1.5k 1.1×	1.3k 1.1×	588 1.1×	564 1.2×	59	4.1k
Elizabeth Nardin United States	37	2.7k 1.1×	1.9k 1.4×	1.6k 1.4×	528 1.0×	667 1.4×	74	4.3k
Yupin Charoenvit United States	35	2.4k 1.0×	1.9k 1.4×	1.9k 1.7×	606 1.2×	698 1.4×	65	4.5k
David E. Lanar United States	42	3.2k 1.3×	1.3k 1.0×	1.5k 1.4×	455 0.9×	625 1.3×	88	4.6k
W. Ripley Ballou United States	32	2.1k 0.9×	1.1k 0.8×	1.1k 0.9×	394 0.8×	749 1.6×	48	3.5k
Wayne T. Hockmeyer United States	29	2.2k 0.9×	1.3k 0.9×	885 0.8×	348 0.7×	760 1.6×	59	3.6k
Richard L. Beaudoin United States	34	2.9k 1.2×	1.1k 0.8×	1.1k 1.0×	345 0.7×	421 0.9×	97	3.9k
Carter L. Diggs United States	28	2.3k 1.0×	1.0k 0.8×	873 0.8×	278 0.5×	473 1.0×	63	3.1k
Walter R. Weiss United States	28	1.6k 0.7×	1.2k 0.9×	1.9k 1.6×	528 1.0×	561 1.2×	52	3.7k
David L. Narum United States	41	3.6k 1.5×	1.2k 0.9×	2.0k 1.7×	438 0.8×	512 1.1×	124	4.8k

Countries citing papers authored by Daniel M. Gordon

Since Specialization

Citations

This map shows the geographic impact of Daniel M. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Gordon more than expected).

Fields of papers citing papers by Daniel M. Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Gordon. The network helps show where Daniel M. Gordon may publish in the future.

Co-authorship network of co-authors of Daniel M. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Gordon. A scholar is included among the top collaborators of Daniel M. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Gordon. Daniel M. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Decker, Michael D., et al.. (2021). Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members. Vaccine. 39(39). 5541–5547. 20 indexed citations

Faix, Dennis J., et al.. (2020). Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel. Vaccine. 38(46). 7323–7330. 16 indexed citations

Greenberg, David P., Corwin A. Robertson, & Daniel M. Gordon. (2013). Prevention and Control of Influenza and Dengue Through Vaccine Development. Pediatric Annals. 42(8). 172–7. 1 indexed citations

Kester, Kent E., James F. Cummings, Christian F. Ockenhouse, et al.. (2008). Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research. Vaccine. 26(18). 2191–2202. 99 indexed citations

Hoffman, Stephen L., Thomas Luke, Imogene Schneider, et al.. (2002). Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoites. The Journal of Infectious Diseases. 185(8). 1155–1164. 526 indexed citations breakdown →

Heppner, D. Gray, et al.. (2001). New World monkey efficacy trials for malaria vaccine development: critical path or detour?. Trends in Parasitology. 17(9). 419–425. 17 indexed citations

Andersen, Steven L., et al.. (1998). Successful Double‐Blinded, Randomized, Placebo‐Controlled Field Trial of Azithromycin and Doxycycline as Prophylaxis for Malaria in Western Kenya. Clinical Infectious Diseases. 26(1). 146–150. 101 indexed citations

Migasena, S, D. Gray Heppner, Dennis E. Kyle, et al.. (1997). SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand. Acta Tropica. 67(3). 215–227. 12 indexed citations

Nosten, François, Christine Luxemburger, Dennis E. Kyle, et al.. (1996). Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. The Lancet. 348(9029). 701–707. 130 indexed citations

10.

Copeland, Robert S., Katherine A. Taylor, A J Oloo, et al.. (1996). Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya. Vaccine. 14(8). 817–827. 27 indexed citations

11.

Gordon, Daniel M., Jeffrey A. Lyon, Dennis W. Stacey, et al.. (1996). Phase I Safety and Immunogenicity Testing of Clinical Lots of the Synthetic Plasmodium falciparum Vaccine SPF66 Produced under Good Manufacturing Procedure Conditions in the United States. American Journal of Tropical Medicine and Hygiene. 55(1). 63–68. 12 indexed citations

12.

Wizel, Benjamin, R A Houghten, Kenneth C. Parker, et al.. (1995). Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.. The Journal of Experimental Medicine. 182(5). 1435–1445. 64 indexed citations

13.

Ballou, W. Ripley, Daniel M. Gordon, D. Gray Heppner, et al.. (1995). Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study. Parasitology. 110(S1). S25–S36. 13 indexed citations

14.

Brown, Arthur E., Pricha Singharaj, H. Kyle Webster, et al.. (1994). Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers. Vaccine. 12(2). 102–108. 37 indexed citations

15.

Gordon, Daniel M. & David M. Grant. (1993). Computing the Mordell-Weil Rank of Jacobians of Curves of Genus Two. Transactions of the American Mathematical Society. 337(2). 807–807. 9 indexed citations

16.

White, Katherine, Daniel M. Gordon, Terence G. Porter, et al.. (1993). Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes. Vaccine. 11(13). 1341–1346. 30 indexed citations

17.

Herrington, D A, Genevieve A. Losonsky, Gale Smith, et al.. (1992). Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine. 10(12). 841–846. 27 indexed citations

18.

Gordon, Daniel M., Donald R. Davis, Michael Lee, et al.. (1991). Significance of Circumsporozoite-Specific Antibody in the Natural Transmission of Plasmodium Falciparum, Plasmodium Vivax, and Plasmodium Malariae in an Aboriginal (Orang Asli) Population of Central Peninsular Malaysia. American Journal of Tropical Medicine and Hygiene. 45(1). 49–56. 17 indexed citations

19.

Brown, Arthur E., et al.. (1991). Characteristics of Natural Antibody Responses to the Circumsporozoite Protein of Plasmodium Vivax. American Journal of Tropical Medicine and Hygiene. 44(1). 21–27. 11 indexed citations

20.

Gordon, Daniel M., Thomas M. Cosgriff, Imogene Schneider, et al.. (1990). Safety and Immunogenicity of a Plasmodium vivax Sporozoite Vaccine. American Journal of Tropical Medicine and Hygiene. 42(6). 527–531. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact